Richard Crowley
Keine laufenden Positionen mehr
Profil
Derzeit ist Richard Crowley Chief Operating Officer & Executive Vice President von Novavax, Inc. In der Vergangenheit war Richard Crowley Executive VP-Operations & Quality Assurance bei TerSera Therapeutics LLC, Co-President & Chief Operating Officer bei Savient Pharmaceuticals, Inc. sowie Senior Vice President-Biopharmaceutical Operations bei ImClone LLC und Director-Biologics Manufacturing bei BASF Bioresearch Corp. Er erwarb einen Bachelor-Abschluss an der Denison University und einen Master-Abschluss an der University of Pennsylvania.
Ehemalige bekannte Positionen von Richard Crowley
| Unternehmen | Position | Ende |
|---|---|---|
| NOVAVAX, INC. | Chief Operating Officer | 20.11.2023 |
Crealta Pharmaceuticals LLC
 Crealta Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Crealta Pharmaceuticals LLC operates as a specialty pharmaceutical company. The firm pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas. The company was founded in August 2013 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | 01.01.2016 |
TerSera Therapeutics LLC
 TerSera Therapeutics LLC Medical SpecialtiesHealth Technology TerSera Therapeutics LLC develops pharmaceutical products. Its therapeutic areas include allergy or immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women's health. The company was founded by Edward J. Fiorentino in 2016 and is headquartered in Lake Forest, IL. | Chief Operating Officer | - |
| SAVIENT PHARMACEUTICALS INC | President | - |
| BASF Bioresearch Corp. | Corporate Officer/Principal | - |
Ausbildung von Richard Crowley
| University of Pennsylvania | Graduate Degree |
| Denison University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
| BASF Bioresearch Corp. | |
Crealta Pharmaceuticals LLC
Crealta Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Crealta Pharmaceuticals LLC operates as a specialty pharmaceutical company. The firm pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas. The company was founded in August 2013 and is headquartered in Lake Forest, IL. | Health Technology |
TerSera Therapeutics LLC
TerSera Therapeutics LLC Medical SpecialtiesHealth Technology TerSera Therapeutics LLC develops pharmaceutical products. Its therapeutic areas include allergy or immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women's health. The company was founded by Edward J. Fiorentino in 2016 and is headquartered in Lake Forest, IL. | Health Technology |
